Applied Genetic Technologies Corporation

NasdaqGM:AGTC Rapporto sulle azioni

Cap. di mercato: US$12.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Applied Genetic Technologies Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

92.6%

Rapporto debito/patrimonio netto

US$16.34m

Debito

Indice di copertura degli interessin/a
ContantiUS$34.24m
Patrimonio nettoUS$17.65m
Totale passivitàUS$39.69m
Totale attivitàUS$57.33m

Aggiornamenti recenti sulla salute finanziaria

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Recent updates

AGTC receives positive feedback from FDA for manufacturing facility

Jul 26

Applied Genetic Technologies proposes stock offering to fund clinical trials

Jul 12

Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022

Jan 12

An Assessment Of Applied Genetic Technologies Corporation

Dec 14

Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk

Jul 15

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Applied Genetic trades lower after announcing the departure of chief scientific officer

Apr 26

What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Feb 05
What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 11
What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic

Nov 11

Analisi della posizione finanziaria

Passività a breve termine: AGTC's short term assets ($37.2M) exceed its short term liabilities ($26.6M).

Passività a lungo termine: AGTC's short term assets ($37.2M) exceed its long term liabilities ($13.1M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: AGTC has more cash than its total debt.

Riduzione del debito: Insufficient data to determine if AGTC's debt to equity ratio has reduced over the past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: AGTC has less than a year of cash runway based on its current free cash flow.

Previsione Cash Runway: AGTC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year


Scoprire le aziende sane